Subclinical synovitis may precede arthritis in anti-CCP2+ individuals
Dec 21, 2021
Anti-CCP3 antibodies were predictive for the development of ultrasound synovitis in anti-CCP2+ at-risk individuals
MRI of hand, foot may predict rheumatoid arthritis in undifferentiated arthritis
Jan 24, 2022
MRI-detected tenosynovitis was independently associated with progression to rheumatoid arthritis.
Model may predict psoriatic arthritis risk in patients with plaque psoriasis
Feb 17, 2022
“The assessment of the risk of PsA in plaque psoriasis patients can help physicians guide patients’ lifestyles and make an individualized treatment plan,” the authors write.
Walking for exercise beneficial for knee osteoarthritis in over 50s
Jun 08, 2022
Those who walked for exercise had a reduced likelihood of new frequent knee pain and medial joint space narrowing.
Progressive resistance training not superior for hip osteoarthritis
Apr 08, 2024
Progressive resistance training was not superior to neuromuscular exercise for improving functional performance, hip pain and quality of life.
Polygenic risk score for OA predicts risk for hip, knee replacement
May 04, 2022
Participants with high PRS’s had an increased risk for joint replacement; a stronger association was seen with hip replacement for women versus men.
Methotrexate reduces pain in hand osteoarthritis with synovitis
Nov 06, 2023
The researchers note a moderate but potentially clinically meaningful effect on reducing hand pain.
Diet and exercise intervention better for pain in knee osteoarthritis
Dec 14, 2022
Among overweight or obese adults, diet and exercise led to a small but significant difference in pain over 18 months versus attention control.
7.6 percent of global population had osteoarthritis in 2020
Aug 22, 2023
Cases of osteoarthritis in the knee, hand, hip and other types are projected to increase considerably by 2050.
CV, cancer risk up with tofacitinib for rheumatoid arthritis
Jan 28, 2022
Incidences of major adverse cardiovascular events and cancers were higher with tofacitinib versus a TNF inhibitor; criteria for noninferiority were not met.